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ABSTRACT OF THE DISSERTATION 
 
Secretory IgA enhances gut B cells priming and systemic IgG responses towards commensals 
by 
You Zhou 
Doctor of Philosophy in Biology and Biomedical Sciences 
Immunology 
Washington University in St. Louis, 2019 
Professor Chyi-Song Hsieh, Chair 
 
IgA is the primary antibody response at mucosal surfaces and is reported to inhibit adaptive 
immune responses against gut bacteria. Here, we utilize an in vitro system to expand and screen 
IgA memory B cells for their ability to recognize gut bacteria in the context of secretory IgA 
(sIgA) deficiency in polymeric Ig receptor (Pigr–/–) mice. Contrary to the prevailing hypothesis 
that IgA provides an immune exclusionary function, we found that mice lacking sIgA showed 
decreased anti-bacterial IgA specificities as assessed using flow cytometry. IgA B cell responses 
against certain taxa such as those of order Bacteriodales showed greater dependence on sIgA. 
Notably, sIgA also facilitated the generation of anti-bacterial IgG B cells, which provided 
increased resistance to intraperitoneal infection by commensal bacteria. Together, these data 
suggest that sIgA can facilitate the immune priming of gut commensals to increase anti-bacterial 
IgA and IgG and enhance immunity.
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Chapter 1: Introduction 
 
 The mammalian gastro-intestinal tract is colonized by trillions of microbes, many of 
which perform symbiotic functions for the benefit of both the host and commensal. However, in 
certain circumstances, colonization of the gut by pathogenic species and virulent penetration into 
the host has been shown to result in pathology (Coburn et al., 2007; Thomson et al., 2011). Thus, 
in order to maintain homeostasis, various host mechanisms have evolved to interact with the 
commensal bacterial population. One layer of protection is thought to be provided by adaptive 
immunity via the secretion of immunoglobulins (Ig) by B cells. While various Ig isotypes are 
produced in the mucosa, secretory IgA (sIgA) is the primary antibody that enters the lumen. 
Recent studies demonstrate the multi-faceted approach in which sIgA can affect the host-microbe 
interaction, oftentimes in the context of pathogenic infection. What is less clear, is the role of 
sIgA responses during homeostatic conditions. In this thesis, we analyze the impact of sIgA 
deficiency on the gut immune system, demonstrate the ability of sIgA to enhance the priming of 
both IgA and IgG memory B cell responses towards commensals, and show the consequences of 
sIgA deficiency during septic challenge by commensal bacteria. 
 
Activation of IgA B cells in the gut. 
The gut IgA B cell compartment develops from naïve B cells of both B1 and B2 origin. 
Naïve B-1 cells are identified as IgMhigh IgDlow and CD5+, while B-2 cells are IgMlow IgDhigh and 
CD5–. Functionally speaking, B-1 B cells are thought to be more “innate-like”, and do not 
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require direct T cell help for activation or class switch; as such, they do not normally show signs 
of affinity maturation (Pabst et al., 2013). B-1 B cells also do not populate follicles such as the 
Peyer’s patches (PP) or mesenteric lymph nodes (MLN) but rather reside in lamina propria or 
peritoneum (Jiang et al., 2004). On the other hand, B-2 B cells represent the more canonical 
adaptive immune response and are thought to be mostly T cell dependent for activation. These B-
2 cells comprise the larger portion of the gut B cell response, and traffic to immune follicles such 
as the PP, cecal patch (cP), or isolated lymphoid follicles (ILF), which are collectively referred to 
as the gut associated lymphoid tissues (GALT) (Lycke and Bemark, 2017). The remainder of this 
review will focus on the development of this population of B cells. 
 The GALT is lined with various specialized cell types that aid in activation of naïve B 
cells (Macpherson et al., 2008). One such group is the follicular associated epithelium (FAE) 
which contains various specialized epithelial cells contributing to B cell activation by allowing 
the controlled influx of lumen antigens. In particular, microfold cells (M cells) are thought to 
have multiple mechanisms for antigen delivery including vesicle mediated bulk transcytosis, 
formation of transcellular pores, and various receptor mediated  mechanisms of antigen capture 
and transcytosis (Mabbott et al., 2013). Indeed, RANKL–/– or RANK–/– mice lacking M cells show 
greatly reduced levels of IgA as well as decreased coating of lumen bacteria by sIgA, thus 
demonstrating the importance of M cells for gut B cell activation (Rios et al., 2016).  The 
intestinal epithelium also contains goblet cells which are able to form goblet associated passages 
capable of delivering soluble antigens to CD103+ dendritic cells (DCs). These CD103+ DCs are 
potent inducers of conventional IgA B cells (McDole et al., 2012). In certain instances such as 
stimulation with a virulent antigen, CD103+ DCs have been shown to extend trans-epithelial 
processes for direct antigen sampling (Farache et al., 2013; Knoop et al., 2013). Suffice to say, 
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there are numerous other mechanisms in which gut antigens can be presented to B cells, and this 
section is not meant to be an exhaustive list of all such mechanisms.  
 Upon antigen encounter and DC stimulation under the FAE, activated B cells upregulate 
CCR6 and home towards its ligand CCL20, which is produced in the subepithelial dome (SED) 
(Reboldi et al., 2016). Within the SED, TGF-β signaling activates the transcription factor CBFα2 
which binds to the Igα germline promoter, resulting in class switch to IgA in an activation-
induced cytidine deaminase (AID) dependent manner (Shi and Stavnezer, 1998). The deletion of 
TGF-β receptor TβRII in B cells results in IgA deficiency, increase in IgG3 class switch, and the 
expansion of B-1 cells (Cazac and Roes, 2000). Recent work has shown that lymphotoxin-α1β2 
(LTα1β2) dependent DCs express a large amount of the integrin αvβ8 (Itgb8), which is 
responsible to cleaving TGF-β into its active form. The loss of  either LTα1β2 or DC specific 
deletion of Itgb8 results in a significant loss of IgA B cell activation (Reboldi et al., 2016). While 
the role of TGF-β on IgA B cell activation is clear, the actual source of TGF-β is less defined. It 
seems likely there are multiple cells producing TGF-β including B cells themselves (Gros et al., 
2014), Tregs, innate lymphoid cells (ILCs), and DCs (Li et al., 2005). While TGF-β is a strong 
inducer of IgA B cells, various other regulating molecules such as IL-5, APRIL, iNOS/TNF, and 
retinoic acid have shown an ability to modulate IgA activation or production through direct and 
indirect mechanisms (Hiroi et al., 1999; Litinskiy et al., 2002; Tezuka et al., 2007; Villablanca et 
al., 2011). 
 Apart from the cytokine signals of the SED, the GALT also contains B cell germinal 
centers (GCs) used for B cell affinity maturation and expansion. Of the distributed gut lymphoid 
tissues, the PP is the dominant site for IgA B cell activation (Reboldi et al., 2016); unlike 
systemic GCs which form following infection or immunization, the PP contains perpetual GCs as 
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a result of the presence of food and microbial antigens (Macpherson et al., 2008). Within the GC 
dark zone, antigen activated B cells undergo cellular expansion and somatic hypermutation 
(SHM). SHM results in the accumulation of randomized mutations on the heavy and light chains 
of the B cell receptor (BCR) and subsequent selection is a process known as affinity maturation, 
resulting in the production of antibodies with stronger affinity towards its antigen (Rajewsky, 
1996). After a yet to be defined signal, these B cells migrate into the light zone where they 
compete for survival signals from follicular helper T cells (TFH) based on the affinity of its BCR 
(Victora et al., 2010). The primary survival signal from TFH cells towards activated B cells is the 
interaction of CD40L to CD40, and the disruption of this signaling axis results in the termination 
of the GC reaction (Bry et al., 2006). However, it should be noted that the lack of CD40L does 
not completely abrogate IgA B cell responses. T-independent IgA B cell activation in CD40L–/– 
mice has been observed in the peritoneal cavity and PP, albeit with impaired protective function 
against common oral challenges such as cholera toxin (Bergqvist et al., 2014).  
 The GC light zone also contains a network of non-hematopoietic follicular dendritic cells 
(FDCs), which contribute to IgA B cell affinity maturation (Suzuki et al., 2010). FDCs present 
antigen to B cells in the light zone by trapping free soluble, complement fixed, or immune 
complexed antigens on their cell surface. It is through competition for these antigens that B cell 
affinity maturation is thought to progress (Heesters et al., 2014). In the case of the PP, IgA 
complexes can be seen along the FDC network, suggesting a feedback role for IgA in priming de 
novo IgA responses (Zhang et al., 2016). 
B cells undergoing the GC reaction can undergo multiple rounds of SHM and selection 
before exiting the GC and becoming mature IgA+ memory B cells (MBCs) or IgA plasma cells 
(PC); this fate decision is often thought to be a result of BCR signaling strength (Bemark et al., 
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2016; Biram et al., 2019). These cells will then recirculate through the systemic lymphatics 
before draining into the thoracic duct and eventually reseeding the small and large intestines 
based on CCR9, CCR10 and α4β7 integrin signals (Hieshima et al., 2014; Kuklin et al., 2001; 
Pabst et al., 2004). Here, a subset of CD80/PDL-2 double negative memory IgA B cells are able 
to re-enter the GC reaction upon reencounter with its cognate antigen (Zuccarino-Catania et al., 
2014), while the IgA plasma cell population represent a temporally stable population of antibody 
secreting cells (Hapfelmeier et al., 2010; Quiding et al., 1991). 
 
B cells and T cells in the MLN 
 While the focus of the previous section has been the activation of IgA B cells in the 
GALT, another site of IgA B cell induction is the MLN. While the MLNs do not have direct 
contact with the microbial contents of the lumen, CD103+ DCs do traffic there and have been 
shown to activate IgA B cell responses (Pabst, 2012). However, the functional difference 
between IgAs generated at the GALT vs. the MLN are unclear, and some studies debate the 
requirement of the MLN for IgA mediated immunity (Hahn et al., 2010). 
 It should be noted however, that the MLNs are a location for T cell activation towards 
gut antigens, and in particular the activation of Foxp3+ regulatory T cells (Treg). For example, 
Helicobacter species have been shown to be a strong inducer of Tregs in the colon draining MLN 
(Chai et al., 2017; Nutsch et al., 2016). Other groups have shown a strong IgA induction 
capability by CD25+ Tregs using the flagellin specific CBir1 transgenic T cell model (Cong et al., 
2009). Finally, a group of Tregs may seed the formation of follicular regulatory cells (TFR). Their 
function may be to limit the number of TFH cells in the GC, as to limit the B:T cell stoichiometry 
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resulting in greater competition for T cell help. Indeed, the deletion of TFR cells has been shown 
to adversely impact B cell affinity maturation (Kawamoto et al., 2014). 
Similarly, studies with Rorγt+ TH17 polarized CBir1 transgenic T cells also show an effect 
on the production of IgA, and depletion of IL-17 receptor (IL-17R–/–) results in a decrease in 
intestinal sIgA levels (Cao et al., 2012). Furthermore, studies show a large migration of TH17 into 
GCs of the diffuse lamina propria after SFB colonization, (Lécuyer et al., 2014). And there is 
some evidence using cell fate mapping techniques demonstrating the conversion of TH17 cells 
into TFH cells (Hirota et al., 2013). However, whether these T cell subsets directly aid IgA B cell 
activation or first convert to Bcl6+ TFH cells first is currently being studied (Crotty, 2011; 
Shulman et al., 2014). Thus, while the MLN may not be the principle site of IgA B cell 
induction, it affects IgA B cells through the development of T cell subsets which interact with B 
cells. 
 
IgA is transported into the gut lumen by polymeric Ig receptor  
While the maturation of naïve B cells into IgA memory and plasma cell populations 
results in the generation of IgA antibody, this is not the final step before IgA can interact with 
the gut microbiome. That is because IgA secreted by plasma cells in the gut are primarily IgA 
dimers (dIgA) linked by the J-chain (Tomasi et al., 1965), which by themselves do not diffuse 
into the lumen. However, upon secretion into the lamina propria, the transmembrane 
glycoprotein polymeric Ig receptor (pIgR) expressed on the basolateral side of the gut epithelium 
covalently binds to the J chain of dIgA (Brandtzaeg and Prydz, 1984) and transports it to the 
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apical surface, whereupon it is cleaved (Norderhaug et al., 1999). An 80 kDa portion of pIgR 
known as the secretory component (SC) stays attached to dIgA, forming sIgA. pIgR is also 
capable of binding to IgM pentamers, also via the J chain. Through this mechanism, IgM is also 
able to be secreted into the gut lumen, albeit at a lower rate than sIgA (Brandtzaeg and Prydz, 
1984). Hence, the transporter pIgR is crucial for allowing IgA interaction with the gut 
microbiome in the lumen. 
Because pIgR is cleaved following transcytosis of IgA, there is a 1:1 stoichiometry 
between the production of pIgR and sIgA (Kaetzel, 2005). This implies the control of pIgR 
expression is tightly correlated with how much sIgA is released into the gut, and the control of 
Pigr gene expression based on environmental stimuli will alter the levels of sIgA. Indeed, 
examination of the intronic and exon 1 regions of the Pigr gene reveals several cytokine reactive 
promoter sites. Briefly, STAT1 and NFκB are two of the primary immune related Pigr promoter 
binding proteins that have been discovered (Johansen and Kaetzel, 2011). Both in vitro and in 
vivo experiments have shown an upregulation of pIgR production after stimulation with IFNγ, 
IL-4, IL-17, TNFα, and various TLR ligands such as LPS (Johansen and Brandtzaeg, 2004). 
Thus, it is thought that various infections and inflammatory events can modulate pIgR expression 
and the subsequent release of sIgA into the lumen. 
 
The functional role of sIgA in the gut 
 Upon secretion into the gut lumen, sIgA has been observed to have a myriad of effector 
functions on the gut microbiome. Unlike IgG and the systemic humoral response, sIgA is not 
thought to mediate a sterilizing immune system such as directing cell killing or complement 
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fixation. Instead, sIgA helps to shape the gut flora through a combination of receptor blockade, 
steric hinderance, immune exclusion, modulating host-microbe interactions, and immune 
surveillance (Mantis et al., 2011).  
The first sIgA effector mechanism reviewed here is the ability to block pathogenic 
virulence factors by steric hinderance. One of the most well known examples of this is the sIgA 
mediated protection of the host from Vibrio cholerae via the blocking of cholera toxin (CT). 
Here, sIgA blockade of CT’s B subunit protein prevented its interaction with the host epithelial 
GM1 toxin receptor, and effectively blocks the onset of diarrhea common to cholera infections. 
Specifically, the generation of IgA hybridomas from the PP of CT orally vaccinated mice binds 
to CT’s B subunit and not the host GM1 receptor, thus showing the mechanism of IgA action is 
through blockade of virulence factors (Apter et al., 1993). Another example of sIgA’s ability to 
neutralize virulence factors comes from a study of Clostridium difficile, whose toxin A and B 
results in enterocolitis in humans and mice. In particular, the authors show that sIgA is more 
effective at neutralizing both toxins than an IgG antibody sharing the same variable domain 
(Stubbe et al., 2000), thereby reducing the pathology associated with C. difficile colonization.  
The ability for sIgA to neutralize pathogenic virulence factors is not limited to bacteria.  
sIgA has also been studied in the context of viral infection and toxin ingestion. For example, 
during infection with enteric reovirus, several sIgA clones have been isolated which blocks 
reovirus type 1 Lang from binding to the host epithelium. Specifically, sIgAs have been 
identified which bind to the reovirus adhesin fiber σ1, thereby blocking entry and pathogenesis 
(Helander et al., 2004). In an example of blockade against toxins, sIgAs neutralizing ricin have 
been described. Following oral immunization of ricin, sIgAs binding to both the ricin enzymatic 
and lectin binding domain were isolated. These antibodies were able to protect host cells from 
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cytotoxicity when co-administered with ricin toxin (Mantis et al., 2006). From these examples, 
we see that sIgA is able to bind a large range of noxious particles for the protection of the host. 
Secondly, sIgA can also mediate host defense by a process broadly known as immune 
exclusion. By enchaining or agglutinating bacteria, sIgA synergizes with the mucus layer of the 
gut and peristalsis to prevent host penetration of  potentially infectious bacteria (Deplancke and 
Gaskins, 2001). One of the best known examples of this occurs during Salmonella enterica 
serovar Typhimurium infection. Here, studies have shown that sIgA targets the LPS O antigen of 
the bacterial outer member resulting in distortion of the membrane and loss of motility (Michetti 
et al., 1992). sIgA has also been shown to bind to the flagella of S. enterica to further reduce its 
motility, thereby preventing its egress deep into the host mucosa (Forbes et al., 2008). 
Furthermore, sIgA can enchain S. enterica at the earlier stages of colonization thereby preventing 
it’s growth (Moor et al., 2017). In studies of other pathogenic bacteria, sIgA is observed to entrap 
Shigella flexneri in the mucus layer, resulting in its excretion through peristalsis. This effector 
function of sIgA is due to both its antigen binding domain as well as the SC, likely due to the 
SC’s ability to interact with the mucin network (Boullier et al., 2009; McGuckin et al., 2011). 
Through its interactions with the mucus layer, IgA has a defined role in preventing bacterial 
penetration into the host. 
Interestingly, immune exclusion does not seem to be the only way in which sIgA controls 
the Shigella pathology. In studies where rabbits were administered Shigella precoated with sIgA 
or Shigella alone, the authors found the addition of sIgA dampened the hosts’ inflammatory 
response by lowering the expression of TNFα, IL-6, and IFNγ (Boullier et al., 2009). The 
dampening of host responses is due to sIgA binding of the outer member O-antigen, which 
causes the down regulated the expression of Shigella’s type 3 secretion system; a virulence factor 
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typically used for pathogenic entry into the intestinal epithelial cells (Forbes et al., 2011) and a 
potent immune stimulator. Thus, by interacting with Shigella, sIgA is observed to modulate 
bacterial protein expression, although the exact mechanism for the downregulation of the type 3 
secretion system is unknown.  
Another example of IgA induced expression change was observed in mice mono-
colonized with Bacteroides thetaiotaomicron (B. theta). In the study by Peterson and colleagues, 
an IgA was isolated that was specific to capsular polysaccharide synthesis 4 (CPS4). The 
exposure of B theta to this IgA resulted in the selection of bacteria with lower expression of 
CPS4, which had lower survival fitness in the mucosa (Peterson et al., 2007b). By altering B. 
theta’s competitive fitness, Peterson and colleagues described a dampening of host inflammatory 
pathways including inducible nitric oxygen species and IFNγ. Thus, IgA exerts a selective 
pressure on a population of B. theta resulting in less host inflammation. 
The ability for IgA to modulate the host immune system is not limited to local cytokine 
secretion, nor is it limited to gut IgA. Work by Koch and colleagues examining the role of 
maternal IgA and IgGs find mouse pups weened without either had a stronger T cell response 
later in life (Koch et al., 2016). Furthermore, the introduction of IgA and IgG in the breast milk 
reduced the number of TFH cells in the developing neonate, resulting in fewer T-dependent IgAs 
later in life. However, the impact of this observation in adult mice is still not clearly understood. 
The concept of quorum sensing by the host and microbe to facilitate homeostasis is interesting, 




Finally, sIgA has one more function that at first glance may seem contradictory to 
everything we’ve described to this point: its ability to bring antigens into the lamina propria. 
Work from Mantis, Corthesy and colleagues have shown sIgA complexed antigens being 
selectively acquired by M cells (Mantis et al., 2002). Microscopy studies show fluorescently 
labelled biotin conjugated to sIgA, but not IgG or IgM, cluster to the apical surface of M cells. 
Furthermore, vesicles within the M cells also showed the presence of fluorescently labelled 
sIgA-biotin complex. Another study visualized this IgA mediated uptake process using mice 
infected with mouse mammary tumor virus (MMTV) in the presence of an IgA hybridoma 
backpack specific to MMTV (Weltzin et al., 1989).  The study noted MMTV glycoprotein gp52 
conjugated with sIgA was found in systemic circulation in the liver and bile. To further support 
the idea of IgA mediated antigen uptake, Rochereau and colleagues demonstrated orally 
administered HIV P24 protein conjugated to IgA, but not IgG, enhanced antigen trafficking and 
improved systemic B cell responses to P24 (Rochereau et al., 2013). 
In order to facilitate reverse transcytosis of antigens, sIgA has been shown to undergo 
conformational changes after binding to antigens. This conformational change improved sIgA 
binding to receptors expressed on the apical surface of M cells (Duc et al., 2010). Further studies 
found Dectin-1 expressed on M cells are responsible for the binding of sIgA complexes 
(Rochereau et al., 2013). These studies showed that Dectin-1 binds to the Cα1 domain and 
various glycoproteins of sIgA. After Dectin-1 binding and reverse transcytosis, the sIgA-antigen 
complex is released into the SED, where CD11c+ CD11b+ DCs expressing the DC-SIGN 
receptor appear to be the primary recipient of these new antigens (Baumann et al., 2010).  Thus, 
the life of the sIgA molecule appears to come full circle, delivering antigens from the lumen into 




The maturation of naïve B cells into memory and plasma IgA B cells is a complex 
process. Multiple different physiological locations, cellular subsets, and cellular signals are 
involved from the initial antigen encounter, the GC reaction, and the secretion of IgA; each of 
which can be modulated based on microbial colonization or inflammatory conditions. It should 
not come as a surprise then, that the factors affecting the formation of IgA B cell responses 
remains an open question. What bacterial antigens do these B cells see at steady state? What 
drives the cross reactive IgA activation versus a more traditional adaptive response? These are 
some of the questions actively being pursued at the moment. 
While the question of IgA B cell activation is complex, so too is the question of sIgA 
function in the lumen. Many of the studies highlighted in the previous section utilized model 
antigens in gnotobiotic mice, oral vaccinations, or pathogenic infections. The function of sIgA 
during homeostasis against a fully complex microbiome is not clearly defined. The paradoxical 
role of sIgA immune exclusion and sIgA immune surveillance is a problem worth addressing. 
Are the two functions truly mutually exclusive, or is it dependent on the target bacteria? 
Addressing these questions and gaining a better understanding of IgA function has the potential 
to unlock many therapeutic innovations, ranging from oral vaccine strategy, to a better 












 Previous studies show mixed results on sIgA’s impact on priming the gut adaptive 
immune response. Depending on the model antigen used, sIgA sometimes blocks T and B cell 
activation, and other times help stimulate the immune response. Here, we utilize an in vitro 
culturing system to expand gut B cells and test the effects sIgA has on the gut adaptive immune 
system under homeostatic conditions with an unaltered microbiome. Interestingly, we see that 
the loss of sIgA in Pigr–/– mice results in lowered IgA MBC responses towards commensals. This 






The mammalian gut is colonized by trillions of microbes which are segregated from the 
host to maintain homeostasis. A number of mechanisms exist to control host:microbial 
interactions, including mucin and antimicrobial peptides at the mucosal surface (Brogden, 2005; 
Hancock et al., 2016; Pelaseyed et al., 2014). Another layer of protection is thought to be 
provided by adaptive immunity via the secretion of immunoglobulins (Ig) by B cells 
(Macpherson et al., 2008; Pabst, 2012). While various Ig isotypes are produced in the mucosa, 
IgA is the primary antibody that enters the lumen. Dimeric IgA, but not IgG, produced by B cells 
is transported from the lamina propria into the gut lumen by the polymeric Ig receptor (pIgR), 
whereupon pIgR is cleaved, leaving the secretory component attached to dimeric IgA forming 
secretory IgA (sIgA) (Mantis et al., 2011). Thus, host IgA responses are thought to be important 
for maintaining homeostasis to gut bacteria (Koch et al., 2016; Macpherson et al., 2008a; Pabst, 
2012). 
The role of sIgA has been extensively studied during infection. Examples include the 
ability of sIgA to enchain enteropathogens such as Salmonella typhimurium to facilitate bacterial 
clearance (Moor et al., 2017), and to neutralize cholera toxin during Vibrio cholerae infection 
(Apter et al., 1993). Secretory IgA (sIgA) has also been implicated as a mechanism for the 
uptake of bacterial antigens (Brown et al., 2013; Mantis et al., 2002) and facilitate 
immunosurveillance of pathogens such as Shigella flexneri (Kadaoui and Corthésy, 2007). Thus, 
sIgA is thought to provide an immunologic barrier during infection. 
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However, the role of sIgA responses to gut commensal bacteria under homeostatic 
conditions is less clear. Previous reports suggest that, similar to its role against pathogens, sIgA 
provides immune exclusion by limiting commensal bacterial antigen access to the adaptive 
immune system (Cong et al., 2009; Peterson et al., 2007a). For example, presentation of orally 
administered flagellin antigen was increased to CBir1 TCR transgenic cells in PigR-deficient 
mice (Cong et al., 2009), which lack the ability to transport IgA into the intestinal lumen. 
However, two recent studies suggested that IgA could facilitate bacterial growth or colonization. 
One study of Bacteroides thetaiotaomicron showed that metabolic utilization of IgA was 
required for optimal colonization (Nakajima et al., 2018). A study of Bacteroides fragilis found 
that host sIgA was used to gain access to certain gut niches to allow colonization (Donaldson et 
al., 2018). These data suggest that the interaction of host immunity and IgA with gut bacteria is 
complex and may occur in a bacteria-specific manner. Thus, while it is clear that host immune 
responses generate sIgA against gut bacteria during homeostasis (Pabst, 2012; Palm et al., 2014), 
it remains unknown whether sIgA facilitates or inhibits the priming of gut B cell responses to 
bacteria.  
Here, we studied the role of sIgA in shaping the anti-commensal Ig repertoire during 
homeostasis. We use the polymeric Ig receptor (Pigr) knockout mouse, which lack the receptor 
required for transporting IgA and IgM into the intestinal lumen, but otherwise do not show overt 
signs of inflammation (Johansen et al., 1999). To efficiently screen for anti-bacterial IgA and 
IgG specificities, we developed an in vitro system to expand small numbers of memory B cells to 
collect their secreted Ig.  Unexpectedly, we found that sIgA deficient mice show decreased IgA 
reactivity towards certain members of the microbiota, suggesting that sIgA facilitated B cell 
priming to gut bacteria. 
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2.3 Materials and Methods 
Ethics Statement 
Animal experiments were performed in specific pathogen free facilities in accordance 




Pigr–/–  mice (Johansen et al., 1999) were obtained from H.W. Virgin, and bred Pigr+/– 
males to Pigr–/– females. CT2 (Nutsch et al., 2016), CT6 (Lathrop et al., 2011), and OTII (Jax 
#004194) TCR transgenic mice have been previously described. Rag1–/– (Jax #002216) and 
Foxp3IRESGFP (Jax #006769) were obtained from Jackson Labs.  
 
T cell analysis and adoptive transfer 
Naïve TCR transgenic T cells from the mesenteric, axillary, and inguinal lymph nodes, 
and spleens, were sorted using a FACAria IIu (Becton Dickenson) based on CD4+ CD25– CD44lo 
CD62Lhi expression. Cells were labelled with Cell Trace Violet (Invitrogen) and 2x105 T cells 
were retro-orbitally injected into 7-8 week old CD45.2 host mice anesthetized with isoflurane. 
After 1 week, the CD45.1+ CD45.2– CD4+ transferred T cells were analyzed by flow cytometry 
from the MLNs. Activated T cells were gated on CD62Llo CD44hi, Foxp3 expression was 
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determined by GFP, and cell proliferation was gated on CTVlo populations. Oral ovalbumin 
(50mg) was fed via gastric gavage 24 and 48 hours after adoptive transfer of OTII cells. 
 
B cell analysis and culture 
Single cell suspensions of ileal PP, colonic lamina propria, or MLN were analyzed by 
flow cytometry. Memory B cell populations were identified as B220+ IgD– CD138– GL7– and 
IgA or IgG+. ASCs were identified as B220lo IgD– GL7– and IgA+ or IgG+. MBCs were expanded 
in vitro via coculture with NIH-3T3 cells expressing BAFF and CD40L as described (Purtha et 
al., 2011). Briefly, MBCs (1-1600/well) were sorted into mitomycin-c treated BAFF and CD40L 
expressing 3T3 cells and cultured in 96 well plates and stimulated with IL2, 6, 10, LPS, 
Pokeweed mitogen, and CpG DNA. After 7 days, supernatant was harvested and IgA/IgG 
quantified by a standard sandwich ELISA using plate-bound anti-mouse IgK capture 
(eBioscience), biotinylated anti-mouse IgA or anti-mouse IgG (BD), and HRP Streptavidin 
(Biolegend). TMB detection was used and quenched with 1M H2SO4; detection was performed at 
A450. Purified mouse IgA or IgG was used to generate standard curves.  
 
Bacteria FACS and sorting 
3 week old Rag1–/– mice were orally gavaged with 200 µL 0.5 g/L vancomycin, 1g /L 
neomycin, ampicillin, and metronidazole twice over 48 hours. 72 hours after the first gavage, 
Rag1–/– mice were gavaged with total intestinal lumen preparations from Pigr+/– or Pigr–/– mice. 
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2 weeks after fecal transfer, intestinal lumen contents and colonic mucus scrapings from Rag1–/– 
mice were collected and frozen in 40% glycerol stocks at -80o C to generate the fecal repository. 
For bacteria FACS, fecal stocks from Rag1–/– mice were treated with 5mM L-acetyl cysteine for 
10 minutes to disrupt the mucous, washed with PBS, and filtered through 70µm nylon mesh. 
20µL were stained with 150µL of Ig containing supernatant in a 96 well U bottom plate on ice 
for 1 hour. Ig-stained intestinal samples were then washed twice with PBS and stained with 1mM 
DAPI, Dylight anti-mouse IgA, PE anti-mouse IgG, and a FITC isotype control for 1 hour on ice. 
After washing, flow cytometry and sorting of bacteria was performed on a BD FACSAria IIu. 
Ig+ fractions were sorted directly into a 96 well PCR plate containing 25µL of H2O.  
 
Bacteria 16S rDNA sequencing 
Bacterial 16S rDNA was amplified using Bioline Ranger polymerase and barcoded 
primers for the V4 region of the 16S rDNA (Caporaso et al., 2011) and sequenced on the 
Illumina MiSEq platform (250 bp paired end reads). OTU picking was performed using 
UPARSE (usearch v.9.0.2132)(Edgar, 2013) and taxonomy assigned via uclust method (QIIME 
v1.9)(Caporaso et al., 2010) using Greengenes 13.8 database. 
 
Statistical Analysis 
Graphpad Prism v8, R v3.5.2, R Studio v1.1.447, and Qiime v1.9 were used for statistical 
and graphical analysis. Student’s t test, Mann-Whitney U test, two-way repeated measures 
ANOVA, Fisher’s exact test (Prism v8 and R package Stats v3.6.0), and PERMANOVA (R 
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package Vegan v2.5-4) were used for between subject analyses. Benjamini-Hochberg FDR 
correction (R package Stats v3.6.0) was to correct for multiple comparisons containing normally 
distributed P values and Storey Q-value correction (R package qvalue v2.14.1) was used to 
adjust for multiple comparisons where P values were left skewed. Outlier detection for high IgA 
reactivity utilized the R packages Extremevalues (v2.3.2) and Fitdistrplus (v1.0-14). Heatmaps 
were generated using R package Heatmap3 (v1.1.16); OTU and wells distance matrices and 
clustering were done using the R package Vegan (v2.5-4). Statistical significance key: * : p < 




sIgA does not affect T cell responses to colonic Helicobacter species 
Previous reports suggested that anti-commensal IgA could inhibit T cell responses to gut 
bacteria (Cong et al., 2009; Peterson et al., 2007a). Recently, we identified Helicobacter 
typhlonius and apodemus as bacterial stimulators (Chai et al., 2017) of peripheral Treg cell 
development of TCR transgenic lines CT2 and CT6 (Lathrop et al., 2011; Nutsch et al., 2016). 
Helicobacter spp. have also been reported to induce IgA responses in vivo (Arnold et al., 2016). 
We therefore asked if activation of these bacterial-reactive T cells was inhibited by sIgA. In 
contrast to CBir1 T cells (Cong et al., 2009), the proliferation and Treg development of 
transferred naïve CT2 and CT6 cells were not affected by loss of sIgA in Pigr–/– mice (Fig. 
2.1.A-C), which were generated in this study by breeding Pigr+/– males with Pigr–/– dams. 
Consistent with the data from transferred TCR transgenic cells, we also did not observe 
wholesale changes in the frequencies of polyclonal effector or regulatory T cells in the Peyer’s 
patches, mesenteric lymph nodes (MLN), or colon lamina propria (cLP) in Pigr–/– compared with 
Pigr+/– mice (Fig. 2.2.A-B). To assess whether Pigr–/– mice exhibited alterations in the 
presentation of soluble oral antigens in unimmunized mice (Johansen et al., 1999), we examined 
OTII responses to oral ovalbumin. Like CT2 and CT6, T cell activation of transferred naïve OTII 
cells was unaffected by PigR-deficiency (Fig 2.1.D). Thus, these data suggest that for these 




sIgA deficient mice show lower IgA reactivity to commensals. 
We then asked whether sIgA limits the B cell response to gut commensals. Similar to the 
polyclonal T cell populations (Fig. 2.2), no significant differences in the IgA+ memory B cells 
(MBC), naïve B cells, or germinal center B cells were seen in the small intestinal Peyer’s Patches 
(PP), MLN, and cLP from 7 week old Pigr–/– and Pigr+/– control littermates (Fig. 2.3.A-B). A 
small increase was found in the antibody secreting cells (ASC) population within the MLN of 
Pigr–/– mice. Overall, the B cell population, like the T cell population, was not markedly affected 
by the absence of sIgA in the gut.  
Although we did not observe marked changes in the B cell population, the absence of 
PigR could still alter the frequency of anti-bacterial B cells. As Pigr–/– mice do not secrete sIgA 
into the lumen (Johansen et al., 1999), this precludes the approach of using flow cytometry for 
assessing IgA specificity for fecal bacterial (Fig. 2.4.A) (Kau et al., 2015; Palm et al., 2014). An 
alternative approach has been to clone from individual IgAs single cells and re-express them to 
test specificity (Tiller et al., 2009). However, this is a time intensive approach and cannot be 
easily used to analyze the antigen specificities of B cell populations between mice of different 
genotypes as only a hundred or so BCR clones can be sampled. Instead of BCR cloning, ex vivo 
culture systems have been used to obtain IgA from ASCs that could then be used to label fecal 
bacteria. However, individual ASCs do not make sufficient IgA in culture (Cocco et al., 2012) to 
assess antigen reactivity at clonal or near-clonal cell numbers.  
Because of these issues, we utilized an ex vivo B cell culture system to study the bacterial 
specificity of IgA produced by MBCs. We chose to study MBCs from the ileal PP, as the PP are 
the primary site for IgA B cell activation in the GALT (Reboldi et al., 2016). Furthermore, the 
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ileum contains the highest number of PPs, and IgA B cells from the ileum also appear to be the 
most mature compared to those found in the duodenum or jejunum (Biram et al., 2019). IgA+ 
MBCs were sorted onto NIH-3T3 cells expressing B cell growth factors (Purtha et al., 2011) and 
expanded in vitro to secrete IgA antibodies. The antibodies in the supernatant were then used to 
stain IgA-free intestinal bacteria and detected by flow cytometry using a fluorescent anti-IgA 
antibody (Fig. 2.5.A). Intestinal bacterial preparations of the small and large intestines were 
generated by antibiotic treatment followed by oral gavage of Rag1–/– mice with fecal matter 
combined from Pigr+/– and Pigr–/– mice. One caveat of this approach is that the microbial 
proportions in the Rag1–/– hosts are not identical to that of the donors, although most of the 
constituents are present in the repository (Fig. 2.5.B). Another issue is that bacteria present at 
low frequency in the repository may be difficult to identify via FACS purification. Finally, flow 
cytometry will not detect anti-bacterial IgA that are reactive to soluble antigens or smaller 
particles such as outer membrane vesicles (Hickey et al., 2015). However, one advantage of an in 
vivo source of bacteria is that they are more likely to express the appropriate array of antigens, 
which may not occur with in vitro culture (Hickey et al., 2015). With these considerations in 
mind, we reasoned that this ex vivo approach would allow us to directly compare the bacterial 
reactive repertoire of PP IgA+ MBCs that develop in the presence or absence of sIgA. 
We first assessed the efficiency of culturing IgA+ MBCs from control Pigr+/– mice in 
vitro. Approximately 17% of wells seeded at one IgA+ MBC per well produced IgA detectable 
by ELISA (Fig. 2.6.A). Of the IgA positive wells, 46% bound bacterial particles as detected by 
flow cytometry, giving an estimated ~8% efficiency per sorted cell for generating bacteria-
reactive IgA. We did not observe a correlation between the IgA concentration in the supernatant 
and the percent IgA bound bacteria, suggesting that the IgA binding is antigen specific (Fig 
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2.6.B). Furthermore, pIgR-deficiency did not lead to a B cell intrinsic IgA production deficit as 
assessed by IgA ELISAs of the in vitro culture supernatants (Fig. 2.6.C). As the limiting factor 
in this analysis was the total number of wells that could be analyzed for IgA-bound bacteria by 
flow cytometry in a given day, we asked whether increasing the number of MBCs input per well 
would allow us to sample a larger proportion of the MBC population in Pigr+/– or Pigr–/– mice. 
Comparison of IgA produced by MBCs from Pigr–/– and Pigr+/– mice wells revealed a difference 
in the frequency of IgA-bound bacteria at 25 cells/well (Fig. 2.7.A). The difference between 
Pigr–/– and Pigr+/– MBCs was diminished or lost at higher cell numbers (100-1000/well), 
suggesting that this assay has a saturable component such as the number of IgA-binding sites on 
bacteria. Twenty-five cells per well would be predicted based on the Poisson distribution to 
result in approximately 1-3 bacteria reactive IgA B cell clones per well, limiting the ability to 
accurately count bacterial-specific MBCs present in the population at high clonal frequency as 
there maybe multiple instances per well. Nonetheless, we reasoned it would be worth this 
tradeoff to capture a substantially greater fraction of the B cell repertoire by using 25 
MBCs/well.  
To confirm the difference seen between MBCs from Pigr–/– or Pigr+/– mice in the cell 
number titration experiment (Fig. 2.7.A), we analyzed supernatants obtained from cultured ileal 
PP IgA+ MBCs sorted from 7 mice per genotype (48 well/mouse; 25 cells/well). As before, the 
frequency of IgA-bound bacterial particles assessed per well by flow cytometry was decreased 
on average from Pigr–/– vs littermate Pigr+/– control MBCs (Fig. 2.8.A). In fact, 24% of IgA 
containing wells from Pigr–/– IgA MBCs showed background levels of binding to bacteria 
(dashed line, Fig. 2.8.A), in contrast with less than 10% of wells from control Pigr+/– MBCs. 
These data suggest that deficiency in sIgA results in decreased generation of bacteria-specific 
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IgA B cells, which is contrary to the hypothesis that sIgA primarily excludes bacteria from 
interacting with the adaptive immune system (Cong et al., 2009; Peterson et al., 2007a).  
 
Deficiency in sIgA does not significantly alter the microbiota 
One potential explanation for the decrease in IgA B cell reactivity in sIgA deficient mice 
would be a large shift in the microbiota between Pigr–/– and Pigr+/– mice, which are weaned as 
littermates by sex, but not genotype, into the same cage. sIgA may regulate the abundance of 
specific bacteria species (Fadlallah et al., 2018; Macpherson et al., 2008a) and disrupt the 
community structure. To address this, we analyzed the microbiota by 16S rDNA sequencing of 
lumen contents of the small intestine and colon, as well as bacteria that were associated with the 
mucosa. We did not observe significant differences in the microbiota at the operational 
taxonomic unit (OTU) or order level taxa between Pigr–/–, Pigr+/–, or Pigr+/+ mice (Fig. 2.9.A, 
PERMANOVA). In addition, principle coordinate analysis (PCoA) of Bray-Curtis dissimilarity 
distances did not reveal distinct clustering by Pigr genotype (Fig. 2.9.B). Finally, we did not 
observe significant differences in alpha-diversity measures between Pigr–/–, Pigr+/–, or Pigr+/+ 
mice (Fig. 2.9.C). In summary, these data from 7 wk old mice do not reveal a marked shift in the 
microbial community resulting from a deficiency in sIgA, suggesting that the increased bacteria 
specificity of IgA B cells from PigR-sufficient mice are a result of a differences in microbial 





sIgA increases IgA B cell reactivity towards specific taxa 
The unexpected decrease in bacteria-reactive IgA produced by MBCs from sIgA 
deficient Pigr–/– mice could be due to a loss of IgA reactivity to specific taxa vs “innate” like IgA 
that are cross-reactive to bacteria from many different taxa (Bunker et al., 2017). To address this, 
we sorted the IgA-bound bacteria labeled by supernatants from the 25-cell pools and analyzed 
their taxonomy by 16S rDNA sequencing (Caporaso et al., 2010).  Comparison of the IgA-bound 
bacteria from each well revealed a number of OTUs that were consistently found, mostly from 
the Bacteroidales order (top rows, Fig. 2.10.A). There were a number of wells that contain 
similar levels of IgA by ELISA, but did not show IgA binding by FACS, arguing against the 
possibility that these taxa express IgA binding proteins or other features that non-specifically 
bind IgA. To assess whether the results seen with 25 cell/well may be due to multiple bacterial 
reactive clones per well, we sequenced IgA bound bacteria using IgA generated from wells with 
5 MBCs, where we expect only one expanded bacterial reactive clone per well (Fig. 2.10.B). 
Together with the 25 well sort data, these data suggest that there are OTUs found in almost all 
wells that may represent background in this assay, OTUs that are often found together as a group 
in a number of wells suggestive of cross-reactive IgA (Bunker et al., 2017), and OTUs found in 
only a few wells suggesting recognition by lower clonal frequency MBCs. Our data are 
consistent with the idea that many/most IgA clones exhibit cross-reactivity to multiple species.  
We then asked whether there were wells that showed IgA binding to specific taxa above 
“background” IgA binding, suggestive of the presence of an IgA clone with high reactivity to 
that OTU. We first looked for OTUs that show a high ratio between the IgA bound frequency 
divided by its frequency in the total population used for staining. However, this method skewed 
towards rare bacteria which had large enrichment ratios due to a small denominator (data not 
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shown). Next, we used non-parametric and parametric methods for outlier detection using the 
16S frequency in the top quartile or above 2 standard deviations (SD), respectively, for all wells 
of both genotypes of a given OTU. While this approach worked for some OTUs, for others it 
appeared to result in false positives (e.g. s541 for interquartile range (IQR)) or false negatives 
(e.g. s3846 for 2xSD) (Fig. 2.11.A, B). One limitation of these approaches is that they are based 
on assumptions regarding the distribution of IgA binding frequency. We therefore examined the 
distribution of data across all wells for each OTU by comparing the skewness and kurtosis (Fig. 
2.11.C) via a Cullen Frey graph (see Methods), which suggested that the best fit distribution of 
frequencies was an exponential distribution. This was further supported by examining the Akaike 
information criterion, where the exponential distribution has the best fit (lowest value) compared 
with other distributions across all OTUs (Fig. 2.11.D). Use of an algorithm for outlier detection 
fitted to an exponential distribution (Fig. 2.11.A, E) allowed us to estimate with greater 
reliability the frequency of IgA MBCs wells that show what we will call “high reactivity” to 
specific bacteria taxa. Using this method, we found that the presence of sIgA resulted in a 
significantly increased frequency of MBCs with high reactivity to a subset of OTUs determined 
(Fig. 2.12.A). In fact, OTUs showing a greater than 4-fold difference in the number of IgA high 
reactivity wells were preferentially bound by IgA MBCs from Pigr+/– compared with Pigr–/– mice 
(Fig. 2.12.B, vertical dashed lines).  
Because these experiments used multiple breeders and litters over a period of weeks to 
months, we performed a pairwise comparison between the individual sIgA-deficient Pigr–/– 
mouse and control Pigr+/– littermate sorted on each experiment day to limit the effects of litter to 
litter variation. For each OTU, we subtracted the number of wells with high reactivity IgA from 
the Pigr+/– vs its paired Pigr–/– littermate–a positive number indicating a greater number of wells 
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with high reactivity to that OTU in the Pigr+/– mouse. For most OTUs, there were more IgA 
reactive wells from the sIgA-sufficient mouse (blue, Fig. 2.12.C). However, a subset of OTUs 
show increased numbers of IgA reactive wells from the sIgA-deficient mouse (red, Fig. 2.12.C). 
Taken together, these data suggest that the presence of sIgA generally enhanced the generation 
of high reactivity IgA to specific taxa.   
We next asked if the sIgA dependent IgA were targeted based on higher taxonomic 
levels, hypothesizing that species of certain taxa may express common antigens. To test this, we 
summed the number of wells showing high IgA reactivity at a given taxonomic level as a 
proportion of total wells and observed that members of the Bacteroidales order elicit a larger IgA 
B cell response in Pigr+/– mice than in Pigr–/– mice (Fig. 2.12.D). Finally, we asked whether 
sIgA affected the anti-IgA coverage of the bacterial species that reside within the gut. We were 
able to detect wells with high IgA reactivity towards ~60% of the commensal population in Pigr–
/– mice compared to ~80% in Pigr+/– mice (Fig 2.12.E). In summary, these data suggest that the 
presence of sIgA enhanced the frequency of bacterial reactive IgA+ MBCs, the proportion of 
clones with high reactivity to gut bacteria, and the breath of bacterial recognition by high 




In this chapter, we show a major role of sIgA is to facilitate B cell responses to 
commensal bacteria, contrary to the notion that sIgA inhibits immune interaction with gut 
bacteria. These responses appeared to be taxa specific, as Ig responses to OTUs from the 
Bacteroidales order show greater dependence on sIgA. 
Our data suggest that under homeostatic conditions, sIgA is not required for preventing 
wholesale commensal bacterial entry into the lamina propria, consistent with a recent study 
(Rogier et al., 2014). Unlike previous studies (Cong et al., 2009; Peterson et al., 2007), we found 
that T cell responses to Helicobacter were not increased in the absence of sIgA. These results 
may differ because the model systems used previously may not represent homeostatic conditions. 
For example, CBir1 T cell activation was assessed to exogenous antigen administered orally and 
not antigen endogenously produced by gut bacteria (Cong et al., 2009). Similarly, decreased T 
cell responses to B. theta was seen in a monocolonized mouse which also had monoclonal 
production of anti-B. theta IgA (Peterson et al., 2007). Another possibility is that Helicobacter, 
which does induce IgA responses in our experience as well as others (Xu et al., 2018), can 
bypass inhibition by sIgA to gain access to the immune system as it lives in crypts of the colon 
and cecum (Pedron et al., 2012). sIgA may still play an immune exclusion role for certain taxa, 
as we observed that some OTUs showed increased IgA+ MBC responses in Pigr–/– vs. Pigr+/– 
mice. In addition, the assay of MBC specificities may not be sensitive to ongoing B cell priming 
which could be diminished by pre-existing IgA. Thus, sIgA may inhibit immune activation to 
only a subset of luminal antigens. 
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Instead, our data suggests that an important role of sIgA during homeostasis is to 
facilitate immunosurveillance. We observed that the frequency of anti-bacterial IgA is increased 
in the presence of sIgA. Although we do not address how this might occur, a mechanism by 
which sIgA facilitates antigen uptake from the gut lumen into the lamina propria was suggested 
to involve Dectin-1 (Rochereau et al., 2013). In addition, sIgA may interact with the gut mucin 
network (Biesbrock et al., 1991), resulting in adherence of bacterial targets to mucin which may 
potentially result in antigen uptake. Future studies will be required to understand the mechanism 
by which sIgA facilitates immune priming, and how it fits amongst the various methods by 
which commensal bacteria trigger adaptive immune responses in the gut. 
OTUs of order Bacteroidales were particularly dependent on sIgA for induction of 
adaptive immunity, although the rationale for this is unclear. One interesting question is whether 
high reactivity antigen-specific sIgA is necessary for this process. Although further studies are 
needed, we speculate that the poly-specificity of many IgA (Bunker et al., 2017), which we 
observed in our studies often binding to Bacteroidales members, may facilitate uptake and 









Figure 2.1: Pigr–/– mice have normal transgenic T cell activation 
(A-D) TCR transgenic responses to gut antigens. TCR transgenic responses to gut antigens. 
2x105 naïve CD45.1 OTII, CT2 or CT6 transgenic T cells were transferred into CD45.2+ Pigr+/– 
or Pigr–/– hosts. MLN (OTII) or distal MLN (CT2, CT6) were analyzed 7 days post transfer and 
donor T cell expression of Foxp3GFP and cellular division (Cell Trace Violet, CTV) was assessed 
by flow cytometry. Representative FACS plots are shown in (A) and summarized in (B-D) for 
CT2, CT6, and OTII, respectively. Significance determined by Student’s t test. Each dot 





Figure 2.2: Pigr–/– mice have normal polyclonal T cell compartments in the gut 
(A) Frequency of helper T cell populations in the GALT. FACS gating strategy and 
summarization of IFNγ+, IL17+, or Foxp3+ T cell populations in the cLP, MLN, or PP of 7-8 
week old Pigr+/– or Pigr–/– mice were assessed by intracellular staining after PMA + Ionomycin 
stimulation. (B) Frequency of follicular T cells in the GALT. PD1+ CXCR5+ CD4+ cells in the PP 
or MLN of 7-8 week old Pigr+/– or Pigr–/– mice were assessed by flow cytometry. Statistical 





Figure 2.3: Pigr–/– mice have normal B cell compartments in the gut 
(A) Frequency of B cells in the GALT and MLN. FACS gating strategy for B220+ IgA+ IgD– 
MBCs or B220lo IgA+ IgD– ASCs is shown on the left. On the right, the frequency of ASCs and 
MBCs within the IgD– B cell population of 7-8 week old Pigr+/– or Pigr–/– is shown within the 
Ileal PP, colon lamina propria (cLP) or mesenteric lymph node (MLN). Significance determined 
by Student’s t test. Each dot represents an individual host and combine 2-3 independent 
experiments. (B) FACS gating strategy for ileal PP B cells is shown on the left. On the right, the 
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frequency of B220+ IgD– GL7+ IgA+ germinal center cells, or B220+ IgD– GL7+ IgA– memory B 
cells of 7-8 week old Pigr+/– or Pigr–/– mice is shown. Statistical significance determined by 
Student’s t test (n = 15, 14). (C) Total cell counts within the PP. Statistical significance 







Figure 2.4: Pigr–/– mice have reduced sIgA in the gut lumen 
(A) Fecal IgA assays of Pigr–/– mice. Data shown are (left) FACS gating for IgA bound bacteria 
of fecal pellets, (middle) summary of IgA bound bacteria from 7-8 week old Pigr+/– or Pigr–/– 





Figure 2.5: Method to detect anti-bacterial IgA specificity in sIgA deficient mice 
(A) Experimental protocol for assessing bacterial reactivity. IgA MBCs are expanded in vitro via 
coculture with NIH-3T3 cells expressing BAFF and CD40L. IgA in the supernatant is used to 
stain intestinal bacteria from Rag1–/– mice for bacterial flow cytometry and 16S rDNA 
sequencing. (B) Bacterial composition of fecal repository vs lumen contents. 16S rDNA 
identities of the fecal repository was compared to lumen contents from Pigr+/– or Pigr–/– small 
intestine (SI) or colon lumen contents. Numbers indicate how many OTUs are unique or in the 





Figure 2.6: Bacteria reactive IgA MBCs represent a fraction of total sorted B cells 
(A) Analysis of clonal expansion efficiency. 864 IgA MBCs from Pigr+/– ileal PPs were single 
cell sorted and expanded via the coculture system as per (Fig. 2.5.A). The number of wells with 
IgA in a given concentration range determined by ELISA is shown in green bars. The standard 
curve for IgA ELISA is shown as a blue line. Expanded wells were tested for bacterial reactivity 
by flow cytometry and summarized in the table. Data are pooled from 3 independent 
experiments. (B) IgA concentration and bacteria binding. IgA concentration from single cell IgA 
MBC supernatants after in vitro expansion was quantified by ELISA and compared with the 
frequency of bacteria binding. (C) IgA concentration versus IgA MBC source. IgA concentration 
from wells containing 25 IgA MBCs from either Pigr+/– or Pigr–/– ileal PPs were determined by 





Figure 2.7: Optimizing IgA MBC sort numbers for sampling resolution vs depth 
IgA bacterial binding and cell numbers used for in vitro culture. IgA MBCs from Pigr+/– or Pigr–
/– ileal PPs were titrated from 25-1600 cells sorted per well and tested for bacteria-reactive IgA 
as per (Fig. 2.5.A). Statistical significance was determined by Student’s t test with Storey fdr 





Figure 2.8: Decreased commensal reactivity of IgA MBCs from Pigr–/– mice 
(A) Role for sIgA for bacterial reactive IgA. IgA MBCs from Pigr+/– or Pigr–/– ileal PPs are 
sorted (25/well) and assessed for bacterial reactivity as per (Fig. 2.5.A). Percent IgA bound 
bacteria from each well is shown. Significance determined by Student’s t test of logged values. 











Figure 2.9: sIgA deficiency does not dramatically alter the microbiota 
Gut commensal bacteria comparison. (A) Bacterial compositions of Pigr+/–, Pigr–/–, or Pigr+/+ 
from colon or SI lumen, or colonic mucosal scrapings. Statistical comparison of compositions for 
various phylogenetic levels done between genotypes for all 3 gut tissues using PERMANOVA. 
(B) PCoA plots of all 3 genotypes and tissue combinations based on weighted Bray-Curtis 
dissimiliarty distances. (C) Alpha diversity of bacterial compositions across genotypes and 






Figure 2.10: 16S of IgA bound bacteria show varying amounts of background binding 
(A) OTUs frequencies of IgA-bound bacteria sorted from MBC cultures as per Fig. 
2.5.A. Data shown are OTUs in rows and individual wells (25 MBC/well) in columns. Left 
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color key indicates which phylogenetic order the OTU belongs to. Clustering uses Bray-
Curtis dissimilarity distances. (B) Analysis of 16S frequencies of IgA enriched OTUs 
from wells using lower numbers of IgA MBCs. 5 IgA MBCs are sorted per well and used 






Figure 2.11: Distinguishing high reactive IgA via outlier detection 
(A) Comparison of three different outlier detection methods. 16S frequencies of each bacterial 
OTU across all wells is plotted against the predicted cutoffs for outlier detection based on 
interquartile range (IQR), 2.5 standard deviations (SD), or outliers based on an exponential 
distribution (EXP). Bottom panel displays the frequency of wells where the OTU is not detected 
in the IgA enriched fraction. (B) Individual OTU (every 15th) 16S frequencies from all wells 
containing 25 IgA MBCs is shown. IQR, SD, EXP cutoffs are plotted. S numbers are an internal 
designation. (C) Distribution of 16S frequencies for select OTUs are shown by Cullen Fray 
graphs. Predicted distribution is shown in blue, and bootstrapped values are shown in orange. 
OTU taxonomic information as per (B). (D) Akaike information criterion of various modelled 
16S frequency distributions. The AIC value for the distribution of 16S frequencies are calculated 
for each OTU. Lower values indicate better fit. (E) Outlier detection of “high reactivity” IgA 
based on a predicted exponential distribution. Plot shows observed 16S frequencies versus the 
residuals based on a predicted exponential distribution. Right upper quadrant highlights the 






Figure 2.12: MBCs from Pigr–/– show decreased IgA reactivity to specific taxa. 
(A) Analysis of IgA MBC reactivity at the OTU level. OTUs that elicited significantly different 
IGA MBC responses between Pigr+/– or Pigr–/– mice as assayed by the 25 cell/well in vitro assay 
per Fig. 2A is shown. Each column represents the log total number of wells with “high 
reactivity” for each OTU per mouse. (B) Effect of sIgA on the number of high reactivity anti-
bacterial IgA MBCs. The number of sorted wells with and without high reactivity IgA for a 
given OTU were compared between Pigr+/– and Pigr–/– samples in a 2x2 contingency table using 














was determined by outlier detection (Fig. S3C-H). The Pigr–/– fraction of all wells with high 
reactivity IgA for that OTU between genotypes is shown on the x-axis (dotted lines denote 4 fold 
differences). (C) Normalization of high reactivity IgA MBCs across litters. Differences between 
the number of high reactivity wells for each OTU were calculated between each Pigr+/– and 
Pigr–/– littermate pair. OTUs with more wells in the Pigr+/– samples are blue; more in Pigr–/– 
samples are red. (D) The role of sIgA on IgA MBC reactivity towards different taxa. The fraction 
of high reactivity IgA wells for a given OTU clustered by phylogenic order per mouse was 
compared between Pigr+/– and Pigr–/– genotypes. Statistical significance was determined by 
Student’s t test with Storey fdr method. (E) Number of OTUs recognized by high reactivity anti-
bacterial IgA MBCs from Pigr+/– and Pigr–/– mice. The total number of OTUs are from 16S 
rDNA sequencing of the lumen of the colon and SI of Rag1–/– mice. An OTU is considered IgA 








 While IgA is the dominant antibody response in the mucosa, the IgG response also make 
up a significant portion of total intestinal B cells. In the previous chapter, we showed that sIgA 
increases the immune priming of IgA MBCs towards commensals. Here, we utilize the 
established in vitro B cell culture and screening system to probe the gut IgG response. We find 
that similar to the IgA response, gut IgG specifies towards commensals are degraded in the 
absence of sIgA. As a result of this loss of IgG specificity, we observe increased morbidity and 
mortality when sIgA deficient Pigr–/– mice are challenged with a sepsis modelling gut barrier 
breach. Finally, we probe the bacterial specificities of the IgA vs IgG response and find the IgA 




The protective role of IgG B cells in systemic immunity is well established (Bruhns, 
2012; Vidarsson et al., 2014a). However, despite comprising a large portion of the gut B cell 
compartment (Zeng et al., 2016), the role of IgG during homeostasis is unclear. Functionally, 
IgG has a different role than its counterpart, IgA. Rather than having the live and let live 
functions associated with IgA (chapter 1), IgG mediate the direct killing of microbes, providing 
sterilizing immunity. Here, we will briefly review the mechanistic properties of IgG distinct from 
IgA. 
One of the functions of IgG is the ability to bind complement. IgG on the surface of a 
microbe can recruit C1q, which is able to initiate the classical complement pathway. The 
activation of complement has two main effects: release of anaphylatoxins (C3a, C5a), and the 
assembly of the membrane attack complex (C5-C9). The anaphylatoxins act as immune 
stimulators, causing the release of histamine from mast cells, and inducing oxidative bursts from 
neutrophils. C3a and C5a also have the ability to stimulate B and T cell expansion and activation 
through the C3a and C5a receptors (Sarma and Ward, 2011). The membrane attack complex is 
able to form cytotoxic pores on the surface of microbes, and the ability of IgG to induce 
hemolysis in bacteria in vitro has been demonstrated (Neuberger and Rajewsky, 1981). It should 
be noted that not all isotypes of IgG are equivalent in binding C1q: IgG1 and 3 are the primary 
activators in humans (Vidarsson et al., 2014a), while IgG2a, 2b and IgG3 are the primary 
activators in mice (Neuberger and Rajewsky, 1981).  
A second function of IgG is associated with its activation of various Fcγ receptors 
expressed on the surface of various immune cells. Fcγ receptor biology is complicated by the 
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number of receptors expressed (7 identified in humans, 5 in mice), and the number of IgG 
isotypes expressed (4 in humans, 5 in mice). Like interactions with C1q, not all IgG isotypes will 
bind to all Fcγ receptors with equal ability; furthermore, Fcγ receptors represent a family of 
receptors with both activating, inhibitory, cell surface expressed and secreted variants (Bruhns, 
2012).  
Activating Fcγ receptors (FcγRI, IIIA, and IV in the mouse) are expressed by a range of 
leukocytes including DCs, monocyte and macrophages, neutrophils, basophils, mast cells, 
eosinophils, and natural killer (NK) cells (Bruhns, 2012). These Fcγ receptors  associate with the 
FcRγ subunit which contain immunoreceptor tyrosine-based activation motifs (ITAM), while IIA 
and IIC contains their own ITAM domains. Upon binding to IgG, the clustering of Fcγ receptors 
results in the phosphorylation of the ITAM motifs by Src family kinases, resulting in the 
recruitment and activation of the tyrosine kinases Syk and ZAP70 (Billadeau and Leibson, 
2008). Activated Syk can then interact with various adaptors depending on cell type to induce 
calcium signaling and PKC signaling which turns on genes for effector function (Getahun and 
Cambier, 2015). Depending on the cell expressing the activating Fcγ receptor, the result can be 
degranulation, phagocytosis, cytokine or iNOS production and antibody-dependent cellular 
cytotoxicity (ADCC). Therefore, activating Fcγ receptors and complement activation represent 
effector functions aimed at the destruction of the IgG targeted microbe. 
As previously mentioned, the Fcγ receptor family also contains an inhibitory receptor, 
FcγRIIb. FcγRIIb is primarily expressed by B cells, and signals through the use of an 
immunoreceptor tyrosine-based inhibitory motif (ITIM). Upon clustering of FcγRIIb, the 
phosphatase SHP-1  is recruited and mediates downstream effects (D’Ambrosio et al., 1995). 
FcγRIIb is thought to interact with the BCR complex by dephosphorylating CD19 and blocking 
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Pi3K signaling (Getahun and Cambier, 2015); the result of this interaction is the inhibition of B 
cell activation or apoptosis. It is thought that FcγRIIb may play a role in affinity maturation, 
when follicular DCs are coated with IgG bound antigens. Therefore, only the B cells expressing 
the highest affinity BCRs could compete against this negative signal (Fournier et al., 2008). 
Finally, a third class of IgG receptor is the neonatal Fc receptor (FcRN). Originally 
described as a receptor responsible for transporting IgG into the mammary glands (Brambell, 
2004), FcRN has also been shown to prolong IgG serum half-life by aiding in its recycling from 
lysosomal degradation (Ghetie et al., 1996). Interestingly, FcRN has also been suggested as a 
vehicle for transporting IgG across mucus barriers such as the lung and gut, thereby acting as an 
IgG homologue to pIgR (Spiekermann et al., 2002; Yoshida et al., 2004, 2006). However in our 
experiments as well as others (Castro-Dopico et al., 2019; Zeng et al., 2016), we do not 
traditionally see IgG in the gut lumen of healthy mice. A possible explanation for this 
discrepancy could be the use of the human-FcRN genetic knock-in model used by Yoshida et al. 
Normally, FcRN is expressed on the gut epithelium in neonatal mice (Bruhns, 2012; Roopenian 
and Akilesh, 2007), but downregulated in adults. It is possible that the expression of hu-FcRN in 
the mouse model does not accurately reflect physiological levels of FcRN in the gut and 
provided a pathway for IgG entry into the lumen that does not normally occur in healthy mice. 
Without a bona fide method of transport into the gut lumen in healthy subjects, the study 
of IgG and its impact on the commensal population has proven difficult. Instead, IgG has 
primarily been studied during infection or inflammation. IgG has been shown to be important for 
clearing luminal infections of attaching and effacing bacteria such as Citrobacter rodentium 
(Maaser et al., 2004). There is also evidence that IgG may exacerbate inflammation by binding 
commensal bacteria in patients with inflammatory bowel disease (Castro-Dopico et al., 2019). 
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Whether anti-commensal IgGs are routinely generated at homeostasis, and whether these IgGs 
are regulated by the presence of sIgA, remains unclear. 
To address this issue, we adapted our in vitro screening system for testing IgA bacterial 
specificities in Pigr–/– to test IgG bacterial specificities. This allowed us to bypass the lumen 
secretion issue that typical gut IgG studies face, as well as compare the anti-commensal IgG 
response in the presence or absence of sIgA. Here, we find that similar to the IgA response, gut 
IgG specifies towards commensals are less robust in the absence of sIgA. By cataloguing the gut 
IgG response, we were able to compare it with the gut IgA response and find that IgG is less 
cross reactive towards gut bacteria than IgA. Finally, we asked if the decrease in IgG responses 
due to sIgA deficiency results in weaker protection against gut bacterial infection. We reasoned 
that IgG typically mediates clearance of invading pathogens, and a decreased IgG response 
would result in susceptibility towards gut bacteria sepsis. Indeed, we find without sIgA, the gut 
IgG is less able to clear invading bacteria resulting in increased morbidity and mortality in our 
gut sepsis model. 
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3.3 Materials and Methods 
Ethics Statement 
Animal experiments were performed in specific pathogen free facilities in accordance 




Pigr–/– mice (Johansen et al., 1999) were obtained from H.W. Virgin, and bred Pigr+/– 
males to Pigr–/– females. Ighm–/– (µMT) mice were obtained from M. Diamond (Jax #002288). 
All mice were on the C57BL/6 genetic background. 
 
B cell analysis and culture 
See chapter 2.3 B cell analysis and culture. 
 
Bacteria FACS and sorting 




Bacteria 16S rDNA sequencing 
See chapter 2.3 Bacteria 16S rDNA sequencing. 
 
Peritoneal bacterial infection 
Luminal contents of small intestines and colon from Pigr+/– and Pigr–/– mice were 
resuspended in 40% glycerol/PBS and aliquots frozen at -80°C. Frozen stocks were thawed and 
grown overnight in 5mL of Brain Heart Infusion (BHI) broth (Sigma-Aldrich 53286) at 37°C 
with shaking. The next day, cultures were diluted 1:100 in 5mL fresh BHI broth and expanded 
until log-phase growth (OD600 of 0.7 – 0.8), spun down, and resuspended in 500µL PBS. 100µL 
was injected I.P. into Pigr+/– or Pigr–/– mice. 24 hours after injection, spleens were collected from 
mice and homogenized in 1 mL PBS using a Roche MagNA lyser (6000 RPM, 1 min). 
Homogenized spleen was diluted 1:102 and 1:104 in PBS and plated as 10 x 20µL drops on BHI 
agar plates, overnight at 37oC. Colonies were then counted for live bacteria before plates were 
scraped using a bacteria pick into 500 µL sterile PBS. 5 µL of picked bacteria were used for 16S 
rDNA amplification and sequencing. 
 
Pasteurella pneumotropica infection 
Pasteurella pneumotropica was isolated from a single colony on BHI agar plates plated 
with homogenized spleens from animals infected i.p. with aerobic gut bacterial cultures. 
Taxonomy was determined by V1-V5 16S Sanger sequencing using universal 10µM 8F/27F (5’-
AGAGTTTGATCCTGGCTCAG-3’ and 5’-AGAGTTTGATCMTGGCTCAG-3’) and 1391R 
54 
 
(5’-GACGGGCGGTGTGTRCA-3’) primers and matched with P. pneumotropica 16S rDNA V4 
MiSeq sequencing. Stocks of this P. pneumotropica isolate were made in 40% glycerol and kept 
at -80°C. 7-8 week old mice were injected i.p. with ~2x1011 CFUs of bacteria in log phase 
growth in 100 µl PBS. Mice were monitored every 8 hours for disease progression up to 72 
hours. A blinded scorer assessed the severity of infection based on a sepsis disease scale from 0-
6 (0, healthy; 6, dead) (Powers et al., 2015). Spleens were collected from mice requiring 
euthanasia (absent righting reflex=score of 4 or 5) or at 72h and homogenized for bacterial CFU 
counts. 
Blood was obtained from 7-8 week old Pigr+/– or Pigr–/– mice by aortic puncture in 
100µL heparin and spun down at 3600xG for 5 minutes to collect plasma Ig. Unpurified plasma 
IgG concentrations were quantified by IgK capture ELISA before being used to stain bacterial 
isolates (Fig. 5D). Serum IgG was then pooled based on Pigr+/– or Pigr–/– genotype and purified 
using Pierce Protein A IgG purification kits (ThermoFisher) per manufacturer instructions. 10µg 




See chapter 2.3 Statistical analysis. 
Comparisons of linear regressions done by ANCOVA in Prism. Gradient boosted 
modeling was done using the gbm package in R (v2.15) with 5 fold cross-validation of a 
bernoulli distribution model generated from a random 75% of wells. This model was tested by 
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the remaining data. 40-160 iterations were performed for each parameter set. Optimization of 
n.minobsinnode, bag.fraction, and interaction.depth for area under the curve (AUC) was 
performed prior to final analysis shown in Fig. 5B. Network analyses was done using Gephi 
(v0.9.2) using the ForcedAtlas2 model. Comparison of survival curves uses the Mantel-Cox log 
ranked test on the Kaplan-Meier curves in Prism. Statistical significance key: * : p < 0.05, ** : 





sIgA enhances the priming of anti-bacterial IgG 
Although IgG is not thought of as the traditional B cell response to gut bacteria during 
homeostasis, IgG B cells represent a substantial fraction of the gut B cell population. We 
therefore asked whether IgG reactivity to gut bacteria might also be affected by the presence of 
sIgA using the same in vitro coculture system. Like IgA MBCs, IgG B cell frequency was not 
affected in Pigr–/– mice (Fig. 3.1.A), but IgG supernatants from Pigr–/– PP MBCs (25/well) 
bound to a lower frequency of bacteria compared with those from Pigr+/– MBCs (Fig. 3.1.B). 
16S rDNA sequencing of IgG bound bacteria revealed that Pigr+/– mice generated more wells 
with “high reactivity” anti-bacterial IgG than their Pigr–/– littermates (Fig. 3.2.A, 3.2.B). At the 
taxonomic order level, we again see a difference in the number of Bacteroidales specific IgG 
MBC wells between Pigr+/– and Pigr–/– mice (Fig. 3.2.C). We also noted that Pigr–/– MBCs had 
a lower IgG coverage of the commensal population compared to Pigr+/– littermates (Fig. 3.2.D). 
Therefore, similar to priming of anti-bacterial IgA, sIgA increases the priming and activation of 
IgG MBCs towards gut commensals.  
 
Commensal specific IgGs exhibit less cross-reactivity than IgA  
We also asked if there was a correlation between the frequency of high reactivity IgA vs 
IgG wells for any given OTU. When we plotted the average number of high reactivity IgA vs 
IgG wells per mouse directed against a particular OTU, we found most OTUs exhibited a strong 
correlation between IgA and IgG reactivity, with the majority of OTUs falling within a 90% 
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prediction interval of the linear regression (Fig. 3.3.A). However, we noticed a significantly 
higher number of high reactivity IgG vs. IgA wells in Pigr+/– mice than in Pigr–/– mice (Fig. 
3.3.A, blue vs red line, respectively). This further supports the hypothesis that IgA bound 
bacteria experience enhanced sampling by the immune system and thus provides positive 
feedback for the induction of IgG responses. 
While we observed a number of similarities with IgA, we did note that fewer OTUs were 
found in each sorted IgG+ well compared to the IgA+ wells (Fig. 3.3.B, 2.10.A) using very 
similar fecal repositories (Fig. 3.3.C). Consistent with the heatmap impression, IgA wells reacted 
towards larger segments of the phylogenetic tree than IgG wells (Fig. 3.4.A). To independently 
confirm this idea, we utilized network analysis to visualize the relationships of OTUs that are 
bound by our IgA or IgG wells. Under this method, we treat each bacterial OTU as a node. Edge 
weights are determined by calculating the Pearson’s Correlation, filtering on edges with p < 0.05; 
thus, a high correlation between two OTUs indicates they are commonly enriched by a well of 
antibodies. Based on graph theory, nodes will “repel” one another unless they are tethered by an 
edge; the stronger the edge- the more often two OTUs are enriched by the same wells, the closer 
in proximity nodes will maintain. We can see in our IgA samples, the OTUs form a large central 
cluster (Fig 3.4.B), meaning these OTUs are often enriched by the same IgAs. This supports the 
idea there are cross reactive IgAs. Conversely, we see much less OTU clustering from the IgG 
samples, suggesting IgG is less cross reactive. This is further supported by the average degree 
measurement of the networks, measuring the average number of edges from each node. IgA 
OTUs have a much higher degree (51.26) compared to IgG (17.36) (Fig 3.4.C). Together, these 




Increased susceptibility to bacterial infection in Pigr–/– mice due to decreased pre-formed IgG 
In contrast to IgA, IgG has a well described pathogen neutralization and clearance 
function. This led us to hypothesize that pre-existing anti-bacterial IgG may act as a safeguard 
against bacterial entry and sepsis in case of barrier breach. To model this, we asked whether gut 
bacteria would be more efficiently cleared after i.p. injection into Pigr+/– vs –/– hosts. At 24 hours 
post injection of aerobic luminal bacteria expanded in vitro, we sacrificed the mice and assessed 
the bacterial burden in the spleen. Consistent with our hypothesis, there were significantly higher 
bacterial CFUs in Pigr–/– mice compared to Pigr+/– littermates (Fig. 3.5.A), suggesting that sIgA 
sufficient mice are better able to control peritoneal infection by aerobic commensal bacteria.  
16S rDNA sequencing of the bacterial colonies from the splenic lysate revealed that these 
bacteria were mostly from the Enterococcus and Streptococcus genus (Fig. 3.5.B). One 
particular OTU, Pasteurella pneumotropica, was preferentially found in Pigr–/– but not Pigr+/– 
splenic cultures (Fig. 3.5.C). P. pneumotropica was rarely identified as a bacterial OTUs 
recognized by IgA or IgG MBCs in our in vitro assay, likely as it was not found or found at very 
low frequency in our repository and therefore difficult to detect (Fig. 3.5.D). To further study the 
immune response to P. pneumotropica, we isolated a pure culture from our colony with the 
identical V4 16S rDNA sequence (Fig. 3.5.E). I.p. injection of only P. pneumotropica resulted in 
increased morbidity and mortality in Pigr–/– mice (Fig. 3.6.A). Splenic CFU counts were high 
from mice that were euthanized due to morbidity (Fig. 3.6.B), and absent or low in mice alive at 
the conclusion of the study (72h), consistent with the hypothesis that disease is caused by 
dissemination of P. pneumotropica. Thus, these data show that Pigr–/– mice are more susceptible 
to peritoneal infection by commensal aerobes such as P. pneumotropica.  
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To determine whether B cells were important for protection against P. pneumotropica, 
we i.p. infected B cell deficient µMT (Ighm–/–) mice. Compared to control Pigr+/– mice, µMT 
mice were highly susceptible to infection, often expiring within 6 hours after injection (Fig. 
3.7.A). This suggested that B cells were essential for protection in this model. To establish that 
this protective effect was due to IgG, we purified plasma IgG from either Pigr+/– or Pigr–/– mice. 
We found that Pigr+/– mice had substantially higher titers of anti-P. pneumotropica IgG than 
Pigr–/– mice as assessed using flow cytometry to cultured P. pneumotropica (Fig. 3.7.B). This 
appeared to be bacteria specific, as increased binding of Pigr+/– IgG was not seen to E. 
casseliflavus, which showed no significant outgrowth in our early screens, or C. rodentium, a 
pathogen not found in our mouse colony (Fig. 3.7.B). Finally, we asked if administration of 
purified IgG could protect Pigr–/– mice from P. pneumotropic peritoneal infection. Consistent 
with the in vitro IgG binding data, IgG harvested from Pigr+/– mice injected i.v. was more 
protective against P. pneumotropica infection that that from Pigr–/– mice (Fig. 3.7.C). Taken 
together, we conclude that the presence of sIgA results in the generation of higher serum titers of 




 In this chapter, we show that sIgA enhances the gut IgG MBC response. Like the effect 
of sIgA on the gut IgA MBC compartment, the increase in IgG reactivity towards gut bacteria is 
OTU specific, and particularly increases reactivity towards bacteria belonging to the 
Bacteroidales order. Furthermore, comparing the gut IgA response to the IgG response against 
bacteria revealed IgA is significantly more cross reactive towards bacteria; being able to bind to 
OTUs spanning across multiple phylogenetic genuses and families. Lastly, we demonstrate the 
deficiency of IgG bacterial reactivity in Pigr–/– mice results in susceptibility to sepsis when 
challenged with gut bacteria. 
An unexpected result in this study was the observation that IgG responses to gut bacteria 
are commonly elicited during homeostasis, and that this was in part dependent on sIgA. These 
data may explain why there is a large population of IgG B cells in the gut generated during 
homeostasis. We hypothesize that these IgG B cells provide a pre-formed IgG response in case 
of barrier breach. While anti-bacterial IgG may contribute to pathology with extensive mucosal 
injury such as that seen in ulcerative colitis (Castro-Dopico et al., 2019), our data, as well as 
generally accepted dogma, suggests that IgG is typically protective (Vidarsson et al., 2014b).  
Consistent with this, we observed that aerobic bacteria such as P. pneumotropica 
introduced intraperitoneal were more lethal in mice without sIgA. However, P. pneumotropica 
may not be the only gut bacteria that is cleared by sIgA dependent IgG; a caveat to our study is 
the way we cultured the total lumen bacteria before injection (Fig 3.5.A). By culturing on BHI 
agar plates, aerobic conditions, and 37o, we are selecting for a very particular subset of bacteria, 
therefore biasing our initial screen. This is probably why we did not see any outgrowth of 
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Clostridiales members in the spleen, despite their high representation in the gut (Edwards et al., 
2013; O'Brien et al., 2071). A change of media, and anaerobic conditions may reveal a further 
subset of bacteria which Pigr–/– are susceptible towards. 
One interesting difference between IgG and IgA was their spectrum of binding to 
bacteria. Both the raw data and computational modelling suggest fewer cross reactive IgGs than 
IgA. This is consistent with the notion that IgG and IgA memory cells do not arise from an 
identical pool of naïve B cells. IgA MBCs are formed from both follicular and extra follicular 
sources, whereas IgG MBCs come from predominantly follicular sources (LeBien and Tedder, 
2008). While extra follicular and T independent mechanisms of IgA class switch have been 
described in isolated lymphoid follicles of the lamina propria (Macpherson et al., 2000), the data 
for extra follicular generation of IgG B cells is not clearly defined in the gut. Future studies are 
required to show that polyreactive IgA MBCs arise from a different developmental origin than 








Figure 3.1: Decreased commensal reactivity of IgG MBCs from Pigr–/– mice 
(A) Frequency of IgG MBCs in the ileal PP. FACS gating of IgD– B220+ IgA– IgG+ MBC 
populations on the left and quantified on the right between Pigr+/– or Pigr–/– mice. Statistical 
significance determined by Student’s t test (n = 15, 17). (B) Role for sIgA in generating bacteria 
reactive IgG. IgG MBCs from Pigr+/– or Pigr–/– ileal PPs were sorted (25/well) and assessed for 
bacterial reactivity as per Fig. 2.5.A. Percent IgG bound bacteria from each well is shown. 






Figure 3.2: IgG MBCs from Pigr–/– show decreased reactivity to specific taxa 
(A) Effect of sIgA on the number of high reactivity IgG wells. Analysis was performed as per 
Fig. 2.12.B for outlier detection of 16S rDNA sequencing data from sorted IgG+ bacteria using 
supernatant from Pigr+/– and Pigr–/– IgG MBCs. (B) Analysis of IgG MBC reactivity at the OTU 
level. OTUs with significantly different numbers of “high reactivity” IgG wells are shown here 
as per Fig. 2.12.A. (C) The fraction of high reactivity IgG MBC responses towards OTUs of a 
given order was compared between Pigr+/– and Pigr–/– samples as per Fig. 2.12.D. (D) Number 












Figure 3.3: Comparison of anti-bacterial reactivity of IgA and IgG MBCs 
(A) Correlation of IgA MBC and IgG MBC bacterial reactivity. Data shown are the average 
number of IgA vs IgG wells across all samples that show high reactivity for an OTU by 
genotype. Linear regression between IgA and IgG shown in solid lines; difference in slopes is 
significant by ANCOVA. Shaded areas indicate the 90% confidence interval for the best fit line. 
(B) OTUs frequencies of IgG-bound bacteria sorted from MBC cultures as per Fig. 2.5.A. Rows 
show individual bacterial OTUs, and columns show individual wells (25 IgG MBC/well). 
Clustering and color key as per Fig. 2.10.A. (C) Fecal repository composition over multiple 
experiments. 5-6 samples of total bacteria for each experiment set as per Fig. 2.8.A and 3.1.B 
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were FACS sorted. 16S rDNA frequencies are shown for the total bacteria content. Clustering 









Figure 3.4: Computational modelling of IgA vs IgG reactivity to bacteria 
(A) Taxonomic breadth of IgA and IgG wells towards commensal bacteria. The number of 
phylogenetic genus, families or orders enriched by each well is shown. Median indicated by 
horizontal line. Significance between IgA and IgG determined by Mann-Whitney U test. (B) 
Network analyses of IgA- or IgG-bound bacteria. Each node is a bacterial OTU. Edge distances 
are calculated via Pearson’s correlation for the association of 16S frequencies between the two 
OTUs across all IgA or IgG samples. Network modelled using Gephi with ForcedAtlas2 
parameters. Color key indicates phylogenetic order of the OTU. (C) Network analysis 
distribution of degrees. Plots show the average number of degrees, or edges, each OTU nodes 
possess for IgA and IgA wells. Larger degree values indicate a higher likelihood of OTUs being 







Figure 3.5: Pigr–/– mice are more susceptible to IP challenge from aerobic bacteria 
(A) Intraperitoneal infection of aerobic gut bacteria. 2x109 CFUs of aerobically cultured 


























colony counts were obtained 24 hours later on BHI agar plates. Statistical significance 
determined by Student’s t test (n = 13 and 11). (B) The effect of sIgA on splenic bacteria after 
peritoneal infection.16S frequency of live bacteria cultured on BHI agar from the spleens of 7-8 
week old Pigr+/– or Pigr–/– 24 hours post i.p. injection with aerobically grown gut bacteria. (C) 
Frequency of P. pneumotropica 16S sequences from splenic cultures. BHI agar plates from (A) 
were scraped and sequenced for 16S rDNA. 16S frequencies of P. pneumotropica are shown (n = 
13 and 11 from 3 independent experiments). Significance determined by Mann-Whitney U test. 
(D) Frequency of P. pneumotropica from the ex vivo MBC screens. 16S rDNA frequencies of P. 
pneumotropica in the IgA enriched fractions from Fig. 2.12.B, IgG enriched fractions from Fig. 
3.2.A, or the fecal library described in Fig. 2.5.B. (E) 16S rDNA sequence of P. pneumotropica 
16S rDNA sequence based on V1-V5 sequencing of cultured isolates (top) and 16S rDNA 





Figure 3.6: Pigr–/– mice are more susceptible to IP challenge from P pneumotropica 
(A) Effect of sIgA on P. pneumotropica infection. 2x1011 CFUs of P. pneumotropica were 
injected i.p. into Pigr+/– or Pigr–/– mice. Survival (left) and morbidity/mortality score (right) was 
monitored for 72 hours. Scoring: 1=Animal is bright and alert; 2=Alert but less active, with 
spontaneous movement; 3=Huddled with ruffled fur, decreased or no spontaneous movement; 
4=Hunched and ruffled, animal does not move when touched, and “righting reflex” absent; 
5=Recumbent; 6=Death. Statistical significance determined by log rank test (left) and repeated 












Figure 3.7: IgG is protective against IP challenge from P pneumotropica 
(A) Requirement for B cells on P. pneumotropica infection. P. pneumotropica was injected IP 
into 7-8 week old µMT or Pigr+/– mice. Disease progress was tracked over 72 hours; historic 
Pigr+/– and Pigr–/– data plotted in dotted lines for reference. Left panel shows survival curve. 
Right panel tracks disease score as per Fig. 3.6.A. (B) Serum IgG reactivity to bacterial isolates. 
Serum from Pigr+/– or Pigr–/– mice was tested for IgG reactivity towards P. pneumotropica, E. 
casseliflavus, or C. rodentium, by flow cytometry; negative control is no serum added. Statistical 
significance determined by ANOVA (n = 4 per group). (C) Effect of IgG on P. pneumotropica 
infection. IgG was purified from the serum of Pigr+/– or Pigr–/– mice and injected i.v. into Pigr–/– 
mice 2 hours prior to i.p. infection with P. pneumotropica and assessed as per Fig. 3.6.A (n = 16 






Chapter 4: Concluding Remarks and 
Future Directions 
 
sIgA increases gut B cell reactivity towards bacteria 
 Our data showed that in sIgA deficient Pigr–/– mice, the activation of IgA and IgG MBCs 
towards gut bacteria is impaired (Figures 2.8, 3.1).  We hypothesize this loss of reactivity is due 
to a reduction in the influx of bacterial antigens into the SED and GC caused by the lack of sIgA 
mediated immune sampling. This defect in IgA and IgG MBC priming effected the immune 
response against certain bacterial OTUs more than others, suggesting certain species are more 
susceptible to sIgA mediated antigen uptake. There may be multiple reasons for this: certain gut 
species may naturally bind more sIgA than others, or they colonize a gut niche that is in closer 
proximity to the receptors responsible for sIgA retro-transport (Pedron et al., 2012). It would be 
interesting to see further experiments aimed at understanding the reason behind sIgA dependent 
immune activation. 
 On the other hand, some OTUs generated higher IgA and IgG MBC responses in Pigr–/– 
mice. There were slightly higher IgA and IgG reactivities detected towards members of the 
Erysipelotrichales and Coriobacteriales orders, respectively (Fig. 2.12.D, 3.2.C). While not 
statistically significant, this does suggest that sIgA can sometimes play a dominantly immune 
exclusionary function towards certain OTUs (Deplancke and Gaskins, 2001; Forbes et al., 
2008b; Moor et al., 2017). One benefit of our in vitro modelling system was its ability to not 
only detect the direction of the gut B cell response, but also approximate the magnitude of the 
response. Thus, we were able to roughly differentiate between OTUs that benefit or are inhibited 
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by sIgA regarding B cell activation. 
 
Clinical implications of sIgA immunosurveillance 
A challenge for understanding the role of IgA is that human patients with IgA deficiency 
are often undiagnosed and do not exhibit a high degree of immunodeficiency (Cunningham-
Rundles, 2001). While this may be in part due to the improved hygiene of modern man, IgA-
deficient patients do show increased frequency of recurrent sinopulmonary infections 
(Cunningham-Rundles, 2001), and increased mortality following liver transplantation (Van Thiel 
et al., 1992). Although future studies will be required to determine if the sIgA dependent 
response we observe in the gut are also seen in the upper airway, our results lead us to speculate 
that these issues may, in part, be due to loss of IgG responses in the absence of IgA.  
Our work demonstrating the connection between the gut IgA and IgG response adds to 
the growing body of literature on how the gut microbiome can affect the systemic immune 
response. It may be possible to leverage this concept into developing an oral vaccine strategy by 
inoculating a subject with viral peptides conjugated to IgA. This should in theory generate an 
IgA as well as IgG response with systemic protection. Indeed, a proof of principle study of this 
was recently published for sIgA-HIV p24 immunization in mice (Rochereau et al., 2015). In 
addition, these findings may also have implications in regards to maternal IgA found in breast 
milk, which we predict will facilitate infant immunity to gut bacteria. Although the effect of 
maternal IgA and IgG has been interpreted as decreasing immune effector T cell activation 
presumably via immune exclusion (Koch et al., 2016), we speculate that an alternative possibility 
75 
 
may be that maternal sIgA facilitated education of the anti-commensal response which led to the 
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